ESR1 and breast cancer: As miR–92 levels decreased in the epithelial component during breast cancer progression we therefore examined the expression level of miR–92 in matched normal fibroblasts (NFs) and cancer-associated fibroblasts (CAFs) previously micro-dissected from 14 patients with ER-positive primary breast cancer [1].